Back | Next |
home / stock / gild / gild message board
Subject | By | Source | When |
---|---|---|---|
Gilead Sciences Inc ($GILD) | mick | investorshub | 03/12/2022 8:03:28 PM |
Gilead Sciences Inc ($GILD) | mick | investorshub | 02/15/2022 9:33:38 PM |
Gilead Sciences Inc ($GILD) | mick | investorshub | 02/06/2022 10:27:48 PM |
$GILD owes ViiV* $1.25B+ 3% royalty on US Biktarvy sales, | DewDiligence | investorshub | 02/02/2022 12:04:10 AM |
$GILD 4Q21 results | DewDiligence | investorshub | 02/01/2022 9:08:45 PM |
https://www.otcmarkets.com/stock/$GILD | mick | investorshub | 01/02/2022 11:12:00 PM |
GILD vs $BMY in LBCL$ CAR-Twho has the edge? | DewDiligence | investorshub | 12/14/2021 12:04:16 AM |
https://www.otcmarkets.com/stock/$GILD | mick | investorshub | 12/12/2021 12:17:35 AM |
$GILD and$ MTNB have been working on ORAL | dhbuzz | investorshub | 12/09/2021 4:13:41 PM |
VIR/$GILD start phase-2 trial testing quadruple regimen of | DewDiligence | investorshub | 12/09/2021 3:06:27 PM |
I Agree: https://www.griproom.com/fun/pfizers-covid-pill-might-not-be-as-great-a | Michel | investorshub | 11/08/2021 12:09:56 PM |
Showtime this week! Brilacidin is a BEAST. Remdesivir | Ultimate01 | investorshub | 11/08/2021 12:05:18 PM |
Gilead Sciences Inc ($GILD) | mick | investorshub | 11/07/2021 5:27:25 PM |
i think so they got ah good pipeline though | mick | investorshub | 11/07/2021 5:27:17 PM |
http://www.ipharminc.com/press-release/2020/9/15/laboratory-testing-of-brilacidi | Michel | investorshub | 11/02/2021 11:33:38 AM |
Mick, I think we are the only ones | slimhere | investorshub | 10/29/2021 2:36:58 PM |
$15 under wow | mick | investorshub | 10/28/2021 9:11:11 PM |
Gilead Sciences Inc ($GILD) | mick | investorshub | 10/28/2021 9:10:40 PM |
5PM, we'll see how close you are, I'm | slimhere | investorshub | 10/28/2021 7:09:44 PM |
$gild should be over $80 to $100 imho | mick | investorshub | 10/10/2021 4:18:04 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-06-14 15:15:06 ET RBC Capital analyst issues UNDERPERFORM recommendation for GILD on June 14, 2024 12:00PM ET. The previous analyst recommendation was Underperform. GILD was trading at $65.16 at issue of the analyst recommendation. The overall analyst consensus : BU...
2024-06-14 15:15:06 ET UBS analyst issues SECTOR PERFORM recommendation for GILD on June 14, 2024 12:00PM ET. The previous analyst recommendation was Sector Perform. GILD was trading at $65.16 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-06-14 15:15:06 ET Evercore ISI analyst issues OUTPERFORM recommendation for GILD on June 14, 2024 11:39AM ET. The previous analyst recommendation was Outperform. GILD was trading at $65.07 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...